KBC Group
VIR icon

KBC Group’s Vir Biotechnology VIR Stock Holding History

KBC Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,958
Closed -$39K – 1816
2025
Q1 		$39K Sell
5,958
-3,012
-34% -$26.8K ﹤0.01% 1833
2024
Q4 		$66K Buy
8,970
+5,177
+136% +$40.8K ﹤0.01% 1759
2024
Q3 		$28K Hold
3,793
– – ﹤0.01% 1832
2024
Q2 		$34K Buy
3,793
+1,274
+51% +$12.2K ﹤0.01% 1794
2024
Q1 		$26K Hold
2,519
– – ﹤0.01% 1801
2023
Q4 		$25K Hold
2,519
– – ﹤0.01% 1845
2023
Q3 		$24K Sell
2,519
-2,980
-54% -$42.5K ﹤0.01% 1857
2023
Q2 		$135K Sell
5,499
-587
-10% -$14.7K ﹤0.01% 1076
2023
Q1 		$142K Sell
6,086
-617
-9% -$15.8K ﹤0.01% 1084
2022
Q4 		$170K Hold
6,703
– – ﹤0.01% 1022
2022
Q3 		$129K Hold
6,703
– – ﹤0.01% 1093
2022
Q2 		$171K Buy
+6,703
New +$156K ﹤0.01% 1032

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return